Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Normanno

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
Recenti Progressi in Medicina|January 19, 2016
[Precision medicine from experimental to clinical applications in oncology]Nicola Normanno
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Gefitinib and cisplatin-based chemotherapy in non-small-cell lung cancer: simply a bad combination?Nicola Normanno
Cancer Discovery|May 16, 2012
HER2 signaling and resistance to the anti-EGFR monoclonal antibody cetuximab: a further step toward personalized medicine for patients with colorectal cancerFortunato Ciardiello, Nicola Normanno
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2010
Osteoblastosis and activating epidermal growth factor receptor mutations: a relationship?David Garfield, Nicola Normanno
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Exploration of Targeted Anti-tumor Therapy: a contribution to the development of targeted therapiesNicola Normanno, Graham Packham
Idrugs : the Investigational Drugs Journal|August 28, 2010
Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumorsAntonella De Luca, Nicola Normanno
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Erlotinib in pancreatic cancer: are tumor cells the (only) target?Nicola Normanno, Antonella De Luca
The New England Journal of Medicine|June 2, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancerAntonella De Luca, Nicola Normanno
Endocrine-Related Cancer|April 8, 2006
Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?Nicola Normanno, William J Gullick
BMC Cancer|April 18, 2015
Genomics driven-oncology: challenges and perspectivesNicola Normanno, Ian A Cree
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
Recenti Progressi in Medicina|January 19, 2016
[Precision medicine from experimental to clinical applications in oncology]Nicola Normanno
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Gefitinib and cisplatin-based chemotherapy in non-small-cell lung cancer: simply a bad combination?Nicola Normanno
Cancer Discovery|May 16, 2012
HER2 signaling and resistance to the anti-EGFR monoclonal antibody cetuximab: a further step toward personalized medicine for patients with colorectal cancerFortunato Ciardiello, Nicola Normanno
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2010
Osteoblastosis and activating epidermal growth factor receptor mutations: a relationship?David Garfield, Nicola Normanno
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Exploration of Targeted Anti-tumor Therapy: a contribution to the development of targeted therapiesNicola Normanno, Graham Packham
Idrugs : the Investigational Drugs Journal|August 28, 2010
Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumorsAntonella De Luca, Nicola Normanno
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Erlotinib in pancreatic cancer: are tumor cells the (only) target?Nicola Normanno, Antonella De Luca
The New England Journal of Medicine|June 2, 2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancerAntonella De Luca, Nicola Normanno
Endocrine-Related Cancer|April 8, 2006
Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application?Nicola Normanno, William J Gullick
BMC Cancer|April 18, 2015
Genomics driven-oncology: challenges and perspectivesNicola Normanno, Ian A Cree
Pageof 31